• Our Company

QuintilesIMS Delivers Integrated Information and Technology Solutions to Drive Healthcare Forward

Around the world healthcare stakeholders are working to improve real-world patient outcomes through treatment innovations, care provision and access to healthcare. For the information, technology and service solutions they need to drive new insights and approaches, they count on QuintilesIMS. With a global team of 50,000, we harness insights, commercial and scientific depth, and executional expertise to empower clients to achieve some of their most important goals: Improving clinical, scientific and commercial results. Realizing the full potential of innovations. And, ultimately, driving healthcare forward.

For more information please visit www.quintilesims.com.

Supporting Evidence-based Decision Making to Advance Healthcare

We are actively engaged with governments, non-governmental organizations (NGOs) and private sector stakeholders to support evidence-based decision making and advance healthcare in Africa. Our global healthcare expertise uniquely positions us to help clients unlock this opportunity and support stakeholder decisions in a range of areas—from access to medicines and care, to market measurement and investment decisions.

QuintilesIMS is investing to expand its presence in Africa, in particular sub-Saharan nations. We are now present in Kenya and are focused on launching new offerings to serve healthcare clients in East Africa and French West Africa in 2014, and are investing to expand into other sub-Saharan nations in 2015/16.

QuintilesIMS is working with the Swiss based, not-for-profit public-private partnership, Medicines for Malaria Venture (MMV), in collaboration with TESS Development Advisors. The agreement covers the collection of information on national pharmaceutical markets, covering all medicines from both the public and private sectors in a number of malaria-endemic countries in sub-Saharan Africa—traditionally a region from where QuintilesIMS has not collected data, and an area where information to assess the public health impact of new pharmaceutical financing mechanisms and policies is needed.

We also work closely with the Life Sciences division of BroadReach Healthcare, where a strategic alliance allows both organizations to deliver comprehensive advisory and commercial effectiveness solutions for life sciences organizations operating in Africa.